1. Uematsu T, Kozawa O, Matsuno H, Niwa M, Yoshikoshi H, Oh-uchi M, et al. Pharmacokinetics and tolerability of intravenous infusion of adenosine (SUNY4001) in healthy volunteers. Br J Clin Pharmacol. 2000;50:177–81.
2. Kajiya T, Kurogane H, Kijima M, Aizawa T, Tanaka T, Yamazaki J, et al. The effects of continuous adenosine infusion on coronary blood flow velocity of patients with effort angina pectoris: comparison between normal and severely stenotic coronary arteries in the same patients. Respir Circ. 2004;52:529–35 (in Japanese).
3. Sakata Y, Nishimura T, Yamazaki J, Nishimura S, Kajiya T, Kodama K, et al. Diagnosis of coronary artery disease by tallium-201 myocardial scintigraphy with intravenous of SUNY4001(adenosine) in effort angina pectoris—the clinical trial report at multi-center: phase. Kaku Igaku. 2004;41:123–32 (in Japanese).
4. Yamazaki J, Nishimura T, Nishimura S, Kajiya T, Kodama K, Kato K. The diagnostic value for ischemic heart disease of thallium-201 myocardial scintigraphy by intravenous infusion of SUNY4001(adenosine)—the report of clinical trial at multi-center: phase. Kaku Igaku. 2004;41:133–42 (in Japanese).
5. Nishimura S, Nishimura T, Yamazaki J, Doi O, Konishi T, Iwasaki T, et al. Comparison of myocardial perfusion imaging by thallium-201 single-photon emission computed tomography with SUNY4001 (adenosine) and excise–crossover clinical trial at multi-center-. Kaku Igaku. 2004;41:143–54 (in Japanese).